May 7 (Reuters) - Anglo-Swedish drugmaker AstraZeneca ( AZN )

is withdrawing its COVID-19 vaccine worldwide, the

Telegraph reported on Tuesday.

The vaccine can no longer be used in the European Union

after the company voluntarily withdrew its "marketing

authorisation", the report stated.

The application to withdraw the vaccine was made on March 5

and came into effect on May 7, according to the report, which

added that similar applications would be made in the UK and

other countries that had approved the vaccine, known as

Vaxzevria, in the coming months.

AstraZeneca ( AZN ) did not immediately respond to a Reuters

request for comment after regular business hours.